Skip to main content

Table 2 Characteristics of study population

From: Targeted CYP2E1 quantification and its correlation to currently acceptable clinical biochemical indices

Variables Study groupings
C (n = 45) Pre-D (n = 25) D (n = 96)
Gender
 M 12 12 47
 F 33 13 49
Age (years) 42 ± 13 50 ± 11 54 ± 9
HbA1c (%) 4.4 ± 0.36 6.0 ± 0.39 8.7 ± 2.0
FBS (mmol L−1) 4.9 ± 0.48 6.0 ± 1.16 10.0 ± 4.68
CYP2E1 (ag µL−1)
  0 ± 0 7.66 ± 16.39 10.0 ± 20.79
 p C vs Pre-D: p < 0.001 C vs D: p < 0.001 Pre-D vs D: p = 0.905
  1. Data are presented as mean ± SD
  2. C control, Pre-D pre-diabetes, D diabetes, m male, f female, FBS fasting blood sugar